Flow

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Flow

Property Description
Active Ingredients Ethinyl Estradiol, Gestodene
Form Tablet (Oral Dosage Form)
Pharmacological Class Combined Hormonal Contraceptive (CHC)
Common Use Prevention of Pregnancy (Contraception)
Origin Synthetic Hormones

What Type of Medicine is Flow?

Flow is a prescription-only medication classified as a Combined Oral Contraceptive (COC), belonging to the broader Combined Hormonal Contraceptive (CHC) pharmacological class. This medication, taken in the form of an oral dosage form (a tablet), is utilized as a daily contraceptive pill intended for women of reproductive age. The combination of synthetic hormones is a characteristic feature that distinguishes it from progestogen-only products. Combined oral contraceptives work to prevent pregnancy by controlling the menstrual cycle. This mechanism supports the medication's primary function in managing reproductive health.

Understanding Flow's Composition

Flow's composition features two distinct active ingredients: Ethinyl Estradiol and Gestodene. Ethinyl Estradiol serves as the synthetic estrogen component, while Gestodene is the synthetic progestogen, recognized specifically as a third-generation progestin. Both components are defined as being of synthetic origin. This established dual-hormone formulation provides the hormonal signal required for contraceptive action. The specific formulation of Ethinyl Estradiol and Gestodene is also shared by other combination pills, such as Minulet and Logest, which utilize this same hormonal combination.

Flow's General Purpose: Why It Is Used

The general purpose of Flow is the prevention of pregnancy, establishing its role as a form of contraception. The drug achieves this benefit through the coordinated effort of its hormonal components, which work to suppress the processes necessary for conception. This effect involves inhibiting ovulation, thickening the cervical mucus, and altering the uterine lining. This structured, biological approach is designed to provide hormone-based contraception for women seeking to manage their reproductive health.

Regulatory References

  1. NIH MedlinePlus

What side effects are possible with Flow?

Possible Side Effects and Safety Information

The safety profile of Flow, a Combined Hormonal Contraceptive (CHC) containing Ethinyl Estradiol and Gestodene, is formally documented by regulatory authorities, classifying risks primarily by frequency and effect on system-organ classes. The most clinically significant aspect is the officially documented, quantifiable risk of thromboembolism.


Serious Adverse Reactions and Vascular Risk

The official labeling highlights a documented risk of serious adverse reactions involving blood clots, known as venous thromboembolism (VTE) (e.g., Deep Vein Thrombosis and Pulmonary Embolism) and arterial thromboembolism (ATE) (e.g., stroke and myocardial infarction). Regulatory agencies quantify the VTE risk for this class of medicine. Additionally, rare but serious risks, including benign and malignant liver tumours and a small, officially documented increase in the risk of breast carcinoma, are part of the long-term safety profile.


Common Adverse Reactions and Safety Patterns

Adverse reactions that are frequently reported, typically classified as common, include effects on the nervous system, gastrointestinal system, and reproductive organs. These commonly reported effects include headache, nausea, vomiting, and breast discomfort or tenderness. Irregular bleeding patterns, such as intermenstrual bleeding or spotting, are also common, particularly during the first three months of use, a documented time-related safety pattern.


Population-Specific Restrictions

Official safety profiles impose strict constraints on use for specific populations. The medicine is formally contraindicated (prohibited) for women over the age of 35 who smoke, and for individuals with a history of severe hepatic disease or pre-existing thrombogenic conditions (e.g., history of VTE/ATE), due to substantially increased risk in these groups.

Overdose and Emergency Response

The official regulatory documents for Flow (Ethinyl Estradiol and Gestodene) define the overdose profile by listing expected, typically non-severe clinical manifestations. Documented overdose presentations commonly include gastrointestinal effects such as nausea and vomiting. Additionally, a key manifestation cited in regulatory labeling is withdrawal bleeding in females, which may occur several days after the event. Other temporary effects noted in the overdose context include dizziness, headache, breast tenderness, and drowsiness or feeling tired.

The severity of an overdose of this medication is consistently reported as low. Regulatory prescribing information explicitly states that there are no reports of serious ill effects documented following the overdose of combined oral contraceptives, including accidental ingestion by children. Consequently, the overdose is not expected to be life-threatening.

Due to the absence of a known or documented specific antidote in the official labeling, the management strategy is defined as symptomatic and supportive treatment. This may involve procedures such as the use of activated charcoal and medical monitoring.

When an overdose is suspected, official government guidance mandates that the user seek immediate medical attention and contact Poison Control right away for guidance. This action is required even though the overdose profile indicates low severity, ensuring proper medical assessment and monitoring.

Therapeutic Uses of Flow

What Flow Treats: Main Uses and Benefits

Flow is commonly used for contraception, and may assist with family planning. Oral contraceptives also are relevant in contexts where additional symptomatic support is needed for symptoms related to systemic imbalance and reproductive health. Beyond its foundational role, the medication is relevant for easing symptoms that interfere with daily functioning by addressing symptoms related to systemic imbalance.

Flow is applied across domains where additional symptomatic support is needed, with relevance to conditions such as severe menstrual cramps, abnormally heavy bleeding, hormonal acne, and supportive management for PCOS and Endometriosis. This approach helps improve day-to-day comfort during symptomatic periods.

Quick Fact: Support for Cyclical Discomfort

Flow may be part of symptomatic management in conditions characterized by periods of heightened symptoms, such as painful and heavy menstruation, offering supportive relief when symptoms become temporarily overwhelming.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Flow (Ethinyl Estradiol and Gestodene) is officially indicated for females of reproductive potential seeking contraception. The drug's eligibility profile is primarily defined by a list of absolute contraindications established by regulatory bodies, focusing heavily on cardiovascular, thromboembolic, and hormone-sensitive conditions.

Populations for Whom Use is Contraindicated

Use of Flow is strictly contraindicated if a woman has a current or past history of:

  • Thromboembolic Events: Including deep venous thrombosis (DVT), pulmonary embolism (PE), stroke, or myocardial infarction.
  • High-Risk Vascular Conditions: Such as severe, uncontrolled hypertension, migraine with aura, or diabetes with vascular complications.
  • Hormone-Sensitive Malignancy: Known or suspected breast cancer or other estrogen-dependent tumors.
  • Severe Hepatic Dysfunction: Severe liver disease, active liver disease, or liver tumors.
  • Pregnancy: The medicine is contraindicated in known or suspected pregnancy.

Specific Eligibility Limitations

Use is generally not recommended for women who are over 35 years of age and smoke, due to significantly increased risks [1.2, 2.4]. Initiation should be delayed for at least four weeks after delivery (if not breastfeeding) or major surgery involving prolonged immobilization [2.3]. Furthermore, Flow is not recommended while breastfeeding, and it is not indicated for use after menopause or before menarche [2.2, 3.5].

What should I know about interactions with other medicines?

Interactions with other medicines and products

Authoritative regulatory documents outline the primary mechanisms by which medicines like Flow may interact with other substances, impacting their pharmacokinetics (how the body handles the drug) or pharmacodynamics (the drug's effect on the body). Clinical practice focuses on managing these known and potential interactions.


Key Interaction Mechanisms

The most common mechanism involves the Cytochrome P450 (CYP) enzyme system in the liver. A drug may be an inhibitor (decreasing metabolism and potentially increasing a co-administered drug's concentration) or an inducer (increasing metabolism and potentially decreasing a co-administered drug's concentration) of specific CYP enzymes, such as CYP3A4, CYP2D6, or CYP2C19. Transporters, like P-glycoprotein (P-gp), also mediate absorption and elimination, and their inhibition or induction by other products can alter drug exposure.

Pharmacodynamic interactions occur when two agents affect the same biological system. For instance, co-administration of drugs that both prolong the QT interval or both cause central nervous system (CNS) depression (e.g., strong sedatives or alcohol) is often classified as a use-with-caution or contraindicated combination, requiring close patient monitoring or specific timing conditions.


Documented Interaction Profile for Flow

Interaction Type Specific Interacting Medicines/Classes
Contraindicated Combinations Not specified in public-facing authoritative sources.
Use-with-Caution Combinations Not specified in public-facing authoritative sources.

Note: Specific, clinically significant interaction data, including dosage adjustments or timing requirements for Flow with particular medicinal products or substance classes, are not available in the public records of major governmental regulatory agencies. Patients should always consult a healthcare professional regarding their complete medication list, including over-the-counter products, supplements, and alcohol, to prevent potential interactions.

Mechanism of Action

How Flow Works: Understanding the Mechanism of Action

Flow's pharmacodynamic action is initiated at the molecular level by interacting with defined receptor subtypes or regulatory enzymes. Its action involves selective modulation of these biological targets, such as acting as a selective antagonist or an allosteric modulator, thereby initiating the adjustment of signaling intensity within the target pathway.

Once bound, Flow's effect extends downstream by influencing complex molecular cascades associated with pathway activation. This process involves the attenuation (weakening) of the signal as it is relayed within the cell, which limits the overall output of specific transmitter or mediator activity. The culmination of this target modulation and pathway influence affects defined regulatory systems within neural or humoral pathways. By applying a targeted adjustment to these processes, the drug contributes to the adjustment of signaling equilibrium and modulates processes characterized by heightened physiological responses.

Dosage and Administration Information

How to use Flow

The use of Flow, a Combined Oral Contraceptive (COC), follows a fixed, continuous cyclic regimen. The approved administration route for this medication is oral, with no preparation requirements specified beyond taking the tablet whole.

Administration Scope

Instruction Domain Official Guideline
Route of administration Oral (swallowed by mouth).
Dosing schedule One tablet taken daily in a 28-day cycle. The cycle includes a prescribed sequence of active hormone tablets followed by inactive/placebo tablets.
Timing in relation to meals May be taken without regard to meals (with or without food).
Special procedural conditions Tablets must be taken at the same time each day and in the exact sequence directed on the blister pack to maintain consistent hormone delivery.
Missed-dose rules Specific protocols apply if administration is delayed. Missing a tablet by more than 12 hours may necessitate following the label's detailed instructions, which often include using additional, non-hormonal contraception for a subsequent period.

Instruction Classifications

Classification Principle
Administration method type Oral (tablet).
Frequency pattern Daily and Continuous Cyclic Use

Resulting Procedural Structure

Official Step Sequence:

  • Take one tablet orally every day, strictly following the established order of the blister pack.
  • Start the new pack immediately after the last inactive tablet of the previous pack is completed, ensuring no extension of the hormone-free interval.

Connection to the Overall Use Protocol

The official instructions establish a rigid, non-titrated, 28-day continuous regimen that relies on fixed daily timing and sequential tablet intake. This highly structured procedural approach governs how the medicine must be taken to maintain the required hormonal pattern.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Flow

Evidence for Use in Pregnancy Prevention (Contraception)

Research exploring how Flow (Ethinyl Estradiol/Gestodene) is used for pregnancy prevention relies on two main types of studies: Randomized Controlled Trials (RCTs) and large-scale observational studies. RCTs are used in research contexts to examine the formulation’s effect on how markers of ovarian function were measured, such as hormonal signals associated with ovulation. Large-scale observational settings evaluating daily-life functioning are used in research exploring how symptoms change over time to follow women over many years to gather long-term data on outcomes.

Trials reported data show patterns related to measurements of hormonal signals. Research explored the relationship between these hormonal patterns and ovulation. Findings also describe patterns observed in the studies related to cycle control, including tracking patterns of unscheduled bleeding, spotting events, and the incidence of amenorrhea during use.

Evidence for Use in Cycle-Related Symptom Management

Research examined patient-reported experiences in studies focused on outcomes related to physical discomfort (e.g., menstrual cramps) and systemic imbalance (e.g., heavy bleeding). These studies include both small RCTs and non-comparative studies where researchers focused on observing responses over defined time intervals.

Studies examined patient-reported outcomes for women who reported specific menstrual symptoms. Findings describe patterns observed related to changes measured during the study period, which were often short-term. Data show patterns related to cycle regularity and changes in the severity of pain. The evidence quality varies across studies, especially because research relies heavily on patient-reported outcomes.

What is Still Uncertain About Flow’s Research Record

Despite the research base, the scientific literature highlights areas where certainty remains low. The existing studies provide limited insight into the long-term patterns for certain complex health outcomes. Furthermore, data for certain groups remain insufficient. For instance, there is limited information for long-term outcomes related to specific ethnic groups or individuals with certain pre-existing chronic conditions.

Key Studies & References Oral Contraceptive Pills - StatPearls (NIH)

Frequently Asked Questions (FAQ)

Common questions about Flow (FAQ)


Q: How quickly does Flow start to work?

Official administration instructions for combined oral contraceptives like Flow often state that a non-hormonal back-up method (such as a condom) should be used for the first seven days of the first cycle. Following the specific instructions for the initial period helps establish the necessary hormonal levels for the medication's intended effect.


Q: How long does the effect of Flow usually last?

The effectiveness of Flow is maintained through daily administration and consistent hormone levels, as required by the regimen. The product labeling generally indicates that if a tablet is missed by more than 12 hours, the contraceptive effectiveness may be reduced, necessitating use of a backup method.


Q: Is it common to feel tired when taking Flow?

Regulatory documents list the most common side effects, such as headache and nausea, but tiredness or fatigue is not typically included among the frequently reported effects. Patients experiencing persistent or unusual symptoms, including fatigue, typically seek guidance from a healthcare provider for clarification.


Q: What happens if I forget to take a dose of Flow suddenly?

Missing a tablet by more than 12 hours may compromise its effectiveness for pregnancy prevention. If this occurs, the detailed protocols provided on the product label are applied, which generally describe the conditions for using additional non-hormonal contraception for a period afterward.


Q: Can I take Flow if I have a history of heart problems?

Flow is formally contraindicated (prohibited) for individuals with a history of specific serious cardiovascular events, including stroke or myocardial infarction, as well as other high-risk vascular conditions. The official product information specifies that contraindications are based on specific, severe heart or vascular issues, requiring careful medical review.


Q: Does Flow affect the ability to drive or operate machinery?

While Flow can cause common side effects like headache that affect the nervous system, official safety data typically states that the medication is not known to impair the ability to drive or operate machinery.


Q: What happens if I accidentally take too much Flow?

Taking a dose higher than prescribed may cause symptoms like nausea, vomiting, or vaginal bleeding/spotting. The official labeling describes the lack of a specific antidote for overdose and notes that medical management is focused on supportive care.


Q: Are the initial side effects of Flow likely to go away?

Official documents note that common side effects, especially irregular bleeding or spotting, are frequently experienced during the first few months of use and may lessen over time. This is a documented, time-related safety pattern.


Q: Does alcohol change the way Flow works in the body?

Official guidance often suggests that alcohol use is an interaction to approach with caution due to possible altered drug effects. The official guidance on this interaction indicates that alcohol consumption is typically reviewed by a healthcare provider while using Flow.


Q: Is it normal to have a slight headache when starting Flow?

Headache is listed in the official documents as a common adverse reaction, meaning it is reported by a noticeable proportion of users. It is an expected side effect, particularly during the initial phase of treatment.


Q: What did the regulatory body (like the FDA) say when they approved Flow?

Flow was approved by regulatory bodies based on research evidence confirming its primary use as a Combined Oral Contraceptive (COC) for the prevention of pregnancy. The approval process relies on scientific data that demonstrates the product's effectiveness and known safety profile.


Q: Does Flow interact with herbal remedies like St. John's Wort?

Yes. Regulatory documents state that herbal products such as St. John's Wort are known to reduce the effectiveness of hormonal contraceptives. This is due to the potential for St. John's Wort to interfere with the metabolism of hormonal components, leading to reduced effectiveness.


Q: Is there a maximum time a person can safely use Flow?

Official documents do not define a specific maximum duration of use for Flow. Instead, they define long-term safety profiles. The medication's continued use is typically reassessed by a healthcare provider in the context of individual risk factors, such as age and smoking status.


Q: Can Flow be used by children?

Flow is not indicated for use before menarche (the onset of menstruation). For adolescents who have begun menstruating, use is typically managed by a healthcare professional based on established clinical guidelines.


Q: Is Flow appropriate for people over 65?

Flow is not indicated for use in women after menopause. This medication is specifically intended for females of reproductive potential for the prevention of pregnancy.


Q: Is Flow safe to use during pregnancy?

Flow is formally and strongly contraindicated (prohibited) in known or suspected pregnancy. The official labeling classifies this as an absolute contraindication, indicating that use is prohibited in known or suspected pregnancy.


Q: Can men use Flow if they are planning to conceive?

Flow is only indicated for use by females of reproductive potential for the prevention of pregnancy. It is not indicated or approved for use by males.


Q: Can Flow cause weight gain or weight loss?

While changes in weight are sometimes mentioned in clinical trial summaries for this class of drug, they are typically not included among the officially documented, most common side effects for Flow. The common effects generally include headache and nausea.


Q: Do I need a special blood test before starting Flow?

Regulatory guidelines require a full medical history and a physical examination before starting the medication. However, a specific, routine blood test before starting is not generally mandated in the public-facing product labeling.


Q: Is Flow addictive or habit-forming?

Flow is a hormonal contraceptive and is not listed in official documents as a controlled substance. The official labeling does not contain warnings related to drug abuse or dependence.


Q: Can Flow be split or crushed, or must it be swallowed whole?

The administration guidelines state that the tablet should be swallowed whole by mouth. Following this established method supports the delivery of the correct dose as required for the medication's intended use.


Q: Is Flow available in a generic version?

Products containing the active ingredients Ethinyl Estradiol and Gestodene are available under different brand names. Generic versions exist for combination products that share the same active ingredients.


Q: Does Flow require a prescription from a specialist?

Flow is classified as a prescription-only medication (Rx Only), meaning it requires a prescription from an authorized healthcare provider. The official label does not typically specify whether the prescriber must be a general practitioner or a specialist.


Q: Can Flow be taken with vitamin supplements?

The official documents recommend that users should discuss all supplements, including vitamin supplements, with their healthcare provider. Official documents describe that the use of supplements, including vitamin supplements, is typically reviewed with a healthcare provider.


Q: Is it true that Flow works better for some people than others?

The research base notes that data is insufficient for certain groups, which suggests a potential for varied effects based on individual characteristics like specific ethnic groups or certain pre-existing chronic conditions. The research evidence indicates that data is limited for certain groups.


Q: Is Flow safe for people with kidney issues?

While Flow is strictly contraindicated for certain severe hepatic (liver) issues, the official labeling does not typically list specific, general contraindications for pre-existing renal (kidney) issues unless they are linked to other severe conditions (e.g., severe hypertension).


Q: Does Flow cause dry mouth?

Dry mouth is not generally included among the officially documented, frequently reported side effects in the core safety labeling. The most common effects are listed as headache, nausea, and breast discomfort.


Q: Can Flow affect my sleep schedule?

While the labeling lists effects on the nervous system, such as headache, specific adverse reactions like insomnia or disruption to the sleep schedule are not typically listed among the most common effects.

How should Flow be stored and disposed of?

How to Store and Dispose of Flow?

Flow (Ethinyl Estradiol and Gestodene Tablets) must be stored and handled according to its official regulatory labeling to ensure chemical stability.

  • Required Temperature: Store the product at a temperature below 30 C (86 F). Storage above this temperature is prohibited.
  • Light Protection: The blister pack must be kept in its outer carton to protect the tablets from light exposure.
  • Child Safety: The medication must be kept out of the sight and reach of children to prevent accidental ingestion.

Disposal

Disposal of any unused or expired Flow product must be carried out in accordance with local requirements. Patients are typically directed to return unused medicines to a pharmacist or use a government-authorized take-back program for appropriate pharmaceutical waste handling, avoiding disposal via household trash or wastewater systems.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Flow found in:

A-Z Index: